Authors:
SOWADE B
SOWADE O
MOCKS J
FRANKE W
WARNKE H
Citation: B. Sowade et al., THE SAFETY OF TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN CLINICAL USE - A REVIEW OF CONTROLLED-STUDIES, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1(2), 1998, pp. 303-314
Authors:
SOWADE O
MESSINGER D
FRANKE W
SOWADE B
SCIGALLA P
WARNKE H
Citation: O. Sowade et al., THE ESTIMATION OF EFFICACY OF ORAL IRON SUPPLEMENTATION DURING TREATMENT WITH EPOETIN-BETA (RECOMBINANT-HUMAN-ERYTHROPOIETIN) IN PATIENTS UNDERGOING CARDIAC-SURGERY, European journal of haematology, 60(4), 1998, pp. 252-259
Authors:
SOWADE O
SOWADE B
GROSS J
BRILLA K
ZIEMER S
FRANKE W
STEPHAN P
SCIGALLA P
WARNKE H
Citation: O. Sowade et al., EVALUATION OF ERYTHROPOIETIC ACTIVITY ON THE BASIS OF THE RED-CELL AND RETICULOCYTE DISTRIBUTION WIDTHS DURING EPOETIN-BETA THERAPY IN PATIENTS UNDERGOING CARDIAC-SURGERY, Acta haematologica, 99(1), 1998, pp. 1-7
Authors:
SOWADE O
SOWADE B
BRILLA K
FRANKE W
STEPHAN P
GROSS J
SCIGALLA P
WARNKE H
Citation: O. Sowade et al., KINETICS OF RETICULOCYTE MATURITY FRACTIONS AND INDEXES AND IRON STATUS DURING THERAPY WITH EPOETIN-BETA (RECOMBINANT-HUMAN-ERYTHROPOIETIN)IN CARDIAC-SURGERY PATIENTS, American journal of hematology, 55(2), 1997, pp. 89-96
Authors:
ZIEMER S
SOWADE O
SOWADE B
FRANKE W
STEPHAN P
REICHE J
GLATZEL E
SCIGALLA P
WAMKE H
Citation: S. Ziemer et al., MARKERS OF COAGULATION FIBRINOLYSIS ACTIVATION, AND WHOLE-BLOOD VISCOSITY (WBV) IN PATIENTS UNDERGOING CARDIAC-SURGERY TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHEPO)/, Thrombosis and haemostasis, 1997, pp. 2142-2142
Authors:
SOWADE O
ZIEMER S
SOWADE B
FRANKE W
MESSINGER D
ZIEBELL E
SCIGALLA P
WARNKE H
Citation: O. Sowade et al., THE EFFECT OF PREOPERATIVE RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY ON PLATELETS AND HEMOSTASIS IN PATIENTS UNDERGOING CARDIAC-SURGERY, The Journal of laboratory and clinical medicine, 129(3), 1997, pp. 376-383
Authors:
SOWADE O
GROSS J
SOWADE B
WARNKE H
FRANKE W
MESSINGER D
SCIGALLA P
LUN A
GLATZEL E
Citation: O. Sowade et al., EVALUATION OF OXYGEN AVAILABILITY WITH OXYGEN STATUS ALGORITHM IN PATIENTS UNDERGOING OPEN-HEART-SURGERY TREATED WITH EPOETIN-BETA, The Journal of laboratory and clinical medicine, 129(1), 1997, pp. 97-105
Authors:
SOWADE O
WARNKE H
SCIGALLA P
SOWADE B
FRANKE W
MESSINGER D
GROSS J
Citation: O. Sowade et al., AVOIDANCE OF ALLOGENEIC BLOOD-TRANSFUSIONS BY TREATMENT WITH EPOETIN-BETA (RECOMBINANT-HUMAN-ERYTHROPOIETIN) IN PATIENTS UNDERGOING OPEN-HEART-SURGERY, Blood, 89(2), 1997, pp. 411-418
Authors:
SOWADE O
WARNKE H
SOWADE B
GROSS J
BAHM J
MESSINGER D
SCIGALLA P
Citation: O. Sowade et al., AVOIDANCE OF HOMOLOGOUS BLOOD-TRANSFUSION AND INCREASE OF OXYGEN AVAILABILITY BY PREOPERATIVE EPOETIN-BETA THERAPY IN PATIENTS UNDERGOING CORONARY-ARTERY BYPASS-GRAFTING (CABG), Blood, 86(10), 1995, pp. 1394-1394